Jose Terencio

Jose Terencio has extensive experience in the biotechnology and pharmaceutical industries, currently serving as Senior Vice President of Discovery at Grifols since June 2008, alongside various leadership roles in Grifols Innovation And New Technologies. Jose is also the CEO of Araclon Biotech S.L. and a board member for multiple organizations, including AlbaJuna Therapeutics SL and VCN Biosciences SL. Prior roles include leadership positions at Grupo Ferrer and a research background in pharmacology. Academic qualifications include a PhD in Biology with a focus on CNS Pharmacology from Universitat de Barcelona, multiple master's degrees, and advanced business training from institutions such as IESE Business School and Singularity University - ESADE.